Page last updated: 2024-12-08

3'-fucosyllactose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3'-fucosyllactose: antiserum against fuc alpha 1-3 gal linkage reacted with human colon adenocarcinoma cells [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161460
SCHEMBL ID19516684
MeSH IDM0109245

Synonyms (6)

Synonym
3'-fucosyllactose
24667-52-5
SCHEMBL19516684
Q617126
DTXSID70947610
6-deoxyhexopyranosyl-(1->3)hexopyranosyl-(1->4)hexopyranose

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" 3-FL was not acutely toxic at 5000 mg/kg bw, and there was no evidence of genetic toxicity in the bacterial reverse mutation test and chromosomal aberration assay."( Safety assessment of the biotechnologically produced human-identical milk oligosaccharide 3-Fucosyllactose (3-FL).
Chan, M; Gibson, C; Hasselwander, O; Himmelstein, MW; Lim, A; Mukerji, P; Mukherjea, R; Myhre, A; Pitt, J; Roper, JM; Sarela, P; Tenning, P, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.67)18.7374
1990's2 (6.67)18.2507
2000's0 (0.00)29.6817
2010's16 (53.33)24.3611
2020's10 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.19 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (3.33%)0.25%
Other27 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]